Underweight at 60-65% benchmark weight; trim to $86.50 stop, retain 35-40% core
The 8/31 Underweight at 60-65% with +0.5% alpha is the binding framework; calibrate conservatively at 60-65% (not 65-70% or 75%) given unverified 9/1 NaN outcome. Stop at $86.50 closing basis with volume >5M (not $86.68 200 SMA which gets run by gap/wick action, not $87.90). Retain 35-40% core for franchise carry (Dividend King, $3.5B FCF, $390M cushion). Re-engage mechanically on 10 EMA reclaim at $90.90 with positive MACD and volume >3.5M, or wait for Q3 2026 as forcing catalyst. Empirical record is unambiguous: trim-to-Underweight generates alpha while bare Hold leaks alpha on this setup.
| Position | Action |
|---|---|
| Default position | 60-65% of benchmark weight |
| Close below $86.50 with volume >5M | Exit residual entirely, wait for 200 SMA retest at $86.68 |
| Q3 2026 miss with margin compression | Trim further toward 40% sizing / Sell |
| Core franchise retention | 35-40% core for franchise carry (~2.37% dividend) |
CL is a defensive quality compounder with elite FCF generation, expanding margins, and 0.33 beta currently offering a 3-to-1 asymmetric risk/reward in a macro regime that favors defensive income stocks — making the current corrective phase a buying opportunity, not a warning sign.
| Indicator | Value | Signal |
|---|---|---|
| Last Close | $89.63 | neutral |
| 200 SMA | $86.68 | bullish |
| 50 SMA | $91.70 | neutral |
| 10 EMA | $90.90 | bearish |
| RSI (14) | 43.37 | neutral |
| MACD | -0.33 | bearish |
| MACD Signal | -0.09 | bearish |
| MACD Histogram | -0.23 | bearish |
| Bollinger Mid (20 SMA) | $91.72 | neutral |
| Bollinger Upper Band | $94.17 | neutral |
| Bollinger Lower Band |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Q3 2026 print (late October) — beat with gross margin expansion and FY27 input-cost discipline
Then: Upgrade to Hold
The current technical corrective phase (below 50 SMA by 2.3%, MACD at -0.23, RSI at 43) is a gift, not a warning — CL remains +3.4% above the 200 SMA at $86.68, with the long-term uptrend intact and a textbook oversold bounce setup developing.
↩ rebuts: “Bear's 'wait for confirmation' technical signal — the 200 SMA at $86.68 is the 'line in the sand for bulls'; until that breaks, every dollar of weakness is a buying opportunity”
EV: +10.8% upside to 52-week high ($99.33) vs ~3.4% downside to 200 SMA support ($86.68), with 2.37% dividend yield; 3-to-1 asymmetric risk/reward · concedes: FX translation noise from strong USD and EM exposure is a known, managed risk, not a surprise; The growth story is modest (~4% CAGR) rather than explosive — this is a quality compounder, not a growth stock; Entry at $89.63 is near the top of the recent range, not at the lows
Operating margin compression and accelerating downside momentum make CL a avoid at current levels, with a 17% downside tail risk to $74.55 if the 200 SMA breaks and FY27 refinancing and FX headwinds not yet priced in.
· concedes: The defensive compounder thesis has merit for long-term holders; CL is a quality business with stable cash flows; The macro defensive-bid thesis is the strongest bull argument, and capital rotation into staples historically does occur in certain risk-off scenarios; The current 13.5x EV/EBITDA vs PG's 17x does represent some relative valuation support; A 200 SMA break triggering an exit is disciplined risk management rather than capitulation
→ vs conservative: 200 SMA at $86.68 is not a cliff but a springboard; with 0.33 beta, $2.95 cushion, and 1.5 ATR working room, the conservative view misreads low-vol support as high-risk
→ vs conservative: Refinancing risk argument borrows concerns from a different company; CL has A+/AA- credit, 1.4x net debt/EBITDA, $3.6B FCF, and is methodically delevering while returning $3B annually—not a leveraged cyclical
→ vs conservative: The 'fragile' 8-10% return framing ignores structural margin improvement; Q2'26 gross margin at 61.5% (highest recent quarter) shows trajectory is up, not a fragile setup
→ vs conservative: Waiting for confirmation ignores 30-to-1 payoff asymmetry; in roughly balanced data with this risk-reward, the answer is not HOLD but a disciplined long with tight stop
→ vs neutral: HOLD with benchmark weight ignores the 10-to-1 to 30-to-1 payoff asymmetry available at $87 entry versus $86.68 stop; that's not rational risk management, that's benchmark hugging
→ vs neutral: Defensive bid is 'not already priced in'; stock at -9.6% from 52-week high means easy money hasn't been made, consolidation is a setup not a verdict
→ vs neutral: 'Margin compression -210 bps YoY' framing is backward-looking; direction of change is up (60.1% to 61.5%) and the conservative narrative misses the trajectory
| $89.27 |
| bullish |
| ATR (14) | $1.88 | neutral |
| VWMA | $91.19 | bearish |
Support: 89.27 · 88.16 · 86.68 | Resistance: 90.9 · 91.7 · 92.55
CL exhibits a textbook correction within a long-term uptrend: price sits below the 10 EMA ($90.90) and 50 SMA ($91.70) but remains above the 200 SMA ($86.68), which continues rising. RSI at 43.37 is weak but not oversold, while MACD histogram has deepened from -0.06 to -0.23 over the past week, signaling accelerating bearish momentum rather than stabilization. Bollinger Bands show price testing the lower band at $89.27, and ATR compression to $1.88 suggests a volatility expansion event is imminent. The analyst recommends HOLD for existing positions and awaits confirmation signals (RSI sub-40 reversal, MACD histogram contraction, or price reclaiming $90.90 on volume) before adding new positions, with $86.68 as the critical trend-defining support.
Market Cap
$71.83B
52-Week High
$99.33
52-Week Low
$74.55
Beta
0.327
Dividend Yield
2.37%
Annual Dividend Rate
~$2.16
P/E (TTM)
35.47x
Forward P/E
21.93x
PEG Ratio
1.63
EPS (TTM)
$2.54
Forward EPS
$4.11
Price/Book
304.4x
Book Value/Share
$0.30
Revenue 2025
$20,382M
Revenue 2024
$20,101M
Revenue 2023
$19,457M
Revenue 2022
$17,967B
Gross Profit 2025
$12,251M
Gross Margin 2025
60.1%
Operating Income 2025
$3,306M
Operating Margin 2025
16.2%
EBITDA 2025
$3,956M
Net Income 2025
$2,132M
Diluted EPS 2025
$2.63
Normalized EPS 2025
~$3.48
Diluted Share Count 2025
811.1M
Q2'26 Revenue
$5,361M
Q2'26 Gross Margin
61.5%
Q2'26 Operating Income
$1,016M
Q2'26 Operating Margin
19.0%
Q2'26 Diluted EPS
$0.86
Cash & Equivalents 2025
$1,288M
Total Assets 2025
$16,330M
Total Debt 2025
$8,554M
Net Debt 2025
$6,700M
Net Debt/EBITDA 2025
1.4x
Stockholders' Equity 2025
$54M
Treasury Stock 2025
$28,450M
Retained Earnings 2025
$26,595M
Operating Cash Flow 2025
$4,198M
CapEx 2025
($564M)
Free Cash Flow 2025
$3,634M
Dividends Paid 2025
$1,823M
Share Repurchases 2025
$1,210M
Total Capital Return 2025
$3,033M
ROA
15.8%
ROIC (est.)
~40%+
Gross Margin (TTM)
60.4%
Operating Margin (TTM)
21.0%
Net Profit Margin
9.7%
EV/EBITDA (est.)
~13.5x
P/S (TTM)
~3.4x
FCF Yield (TTM)
~5.1%
Revenue CAGR 4Y
~4.3%
Strengths
Concerns
HOLD